[{"id":"729dd6a2-45ba-450d-b222-251f402464f1","acronym":"","url":"https://clinicaltrials.gov/study/NCT06461338","created_at":"2025-02-26T14:13:55.381Z","updated_at":"2025-02-26T14:13:55.381Z","phase":"","brief_title":"Acupuncture for Enhancing Immunotherapy in Advanced NSCLC：a Pilot Study","source_id_and_acronym":"NCT06461338","lead_sponsor":"Guangzhou University of Traditional Chinese Medicine","biomarkers":" CEACAM5 • KRT19","pipe":"","alterations":" ","tags":["CEACAM5 • KRT19"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 08/01/2024","start_date":" 08/01/2024","primary_txt":" Primary completion: 02/01/2025","primary_completion_date":" 02/01/2025","study_txt":" Completion: 09/01/2026","study_completion_date":" 09/01/2026","last_update_posted":"2024-08-15"},{"id":"5c9414e8-7220-42f4-8441-a2cd65e87bf3","acronym":"","url":"https://clinicaltrials.gov/study/NCT05463107","created_at":"2022-07-18T14:01:53.359Z","updated_at":"2024-07-02T16:35:14.098Z","phase":"","brief_title":"Correlation Between Various Urinary Exosomal Protein Biomarkers and Pathological Manifestation in Thyroid Follicular Neoplasm: Early and Pre-operative Diagnosis of Follicular Thyroid Cancer","source_id_and_acronym":"NCT05463107","lead_sponsor":"National Taiwan University Hospital","biomarkers":" KRT19 • KRT8 • TG","pipe":"","alterations":" ","tags":["KRT19 • KRT8 • TG"],"overall_status":"Recruiting","enrollment":" Enrollment 50","initiation":"Initiation: 08/01/2022","start_date":" 08/01/2022","primary_txt":" Primary completion: 07/31/2025","primary_completion_date":" 07/31/2025","study_txt":" Completion: 07/31/2028","study_completion_date":" 07/31/2028","last_update_posted":"2024-03-19"},{"id":"c0fa7b11-1ff5-4745-b5b0-98d6ce2329bd","acronym":"","url":"https://clinicaltrials.gov/study/NCT00280202","created_at":"2021-01-18T00:57:15.755Z","updated_at":"2024-07-02T16:35:53.488Z","phase":"","brief_title":"Detection of Genetic Markers of Lung Cancer","source_id_and_acronym":"NCT00280202","lead_sponsor":"University of Pittsburgh","biomarkers":" FASLG • FADD • FAS • KRT19","pipe":" | ","alterations":" TILs","tags":["FASLG • FADD • FAS • KRT19"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TILs"],"overall_status":"Recruiting","enrollment":" Enrollment 6000","initiation":"Initiation: 06/01/1996","start_date":" 06/01/1996","primary_txt":" Primary completion: 12/01/2050","primary_completion_date":" 12/01/2050","study_txt":" Completion: 12/01/2050","study_completion_date":" 12/01/2050","last_update_posted":"2023-03-13"},{"id":"69dace63-4b68-4159-b285-39909111e110","acronym":"","url":"https://clinicaltrials.gov/study/NCT04389216","created_at":"2021-01-18T21:11:12.565Z","updated_at":"2024-07-02T16:35:54.490Z","phase":"","brief_title":"Radiofrequency Ablation (RFA) in Breast Tumors","source_id_and_acronym":"NCT04389216","lead_sponsor":"Hospital Universitari de Bellvitge","biomarkers":" KRT19","pipe":"","alterations":" ","tags":["KRT19"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 05/01/2020","start_date":" 05/01/2020","primary_txt":" Primary completion: 12/15/2024","primary_completion_date":" 12/15/2024","study_txt":" Completion: 12/15/2024","study_completion_date":" 12/15/2024","last_update_posted":"2023-03-01"},{"id":"4953a1bf-5abc-4d0f-a83c-e35443af9380","acronym":"","url":"https://clinicaltrials.gov/study/NCT04948437","created_at":"2021-07-02T12:52:35.475Z","updated_at":"2024-07-02T16:36:02.236Z","phase":"","brief_title":"Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer","source_id_and_acronym":"NCT04948437","lead_sponsor":"National Taiwan University Hospital","biomarkers":" KRT19 • KRT8 • TG","pipe":"","alterations":" ","tags":["KRT19 • KRT8 • TG"],"overall_status":"Recruiting","enrollment":" Enrollment 103","initiation":"Initiation: 08/19/2021","start_date":" 08/19/2021","primary_txt":" Primary completion: 10/31/2024","primary_completion_date":" 10/31/2024","study_txt":" Completion: 10/31/2026","study_completion_date":" 10/31/2026","last_update_posted":"2022-10-18"},{"id":"b8578e8d-7833-452c-bdde-46cc07292ef8","acronym":"","url":"https://clinicaltrials.gov/study/NCT05046366","created_at":"2021-09-16T14:52:58.365Z","updated_at":"2024-07-02T16:36:20.666Z","phase":"","brief_title":"Development of an Artificial Intelligence System for Intelligent Pathological Diagnosis and Therapeutic Effect Prediction Based on Multimodal Data Fusion of Common Tumors and Major Infectious Diseases in the Respiratory System Using Deep Learning Technology.","source_id_and_acronym":"NCT05046366","lead_sponsor":"Wuhan Union Hospital, China","biomarkers":" MUC1 • CEACAM5 • B2M • KRT19 • CRP","pipe":"","alterations":" ","tags":["MUC1 • CEACAM5 • B2M • KRT19 • CRP"],"overall_status":"Recruiting","enrollment":" Enrollment 1000","initiation":"Initiation: 10/01/2021","start_date":" 10/01/2021","primary_txt":" Primary completion: 12/01/2023","primary_completion_date":" 12/01/2023","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2021-11-16"},{"id":"814bc191-bea8-4066-85e7-7ed00e111782","acronym":"CK-CEUS","url":"https://clinicaltrials.gov/study/NCT02992067","created_at":"2021-01-18T14:43:04.223Z","updated_at":"2024-07-02T16:36:54.860Z","phase":"","brief_title":"CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer","source_id_and_acronym":"NCT02992067 - CK-CEUS","lead_sponsor":"Zhejiang Cancer Hospital","biomarkers":" KRT19","pipe":"","alterations":" ","tags":["KRT19"],"overall_status":"Completed","enrollment":" Enrollment 359","initiation":"Initiation: 04/01/2015","start_date":" 04/01/2015","primary_txt":" Primary completion: 04/01/2017","primary_completion_date":" 04/01/2017","study_txt":" Completion: 07/01/2017","study_completion_date":" 07/01/2017","last_update_posted":"2019-10-04"},{"id":"13e8f40a-eabc-496f-b709-6fddc7d25c5e","acronym":"","url":"https://clinicaltrials.gov/study/NCT03432156","created_at":"2021-01-18T16:55:45.604Z","updated_at":"2024-07-02T16:37:04.547Z","phase":"Phase 2","brief_title":"Autologous Tcm Cells Immunotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC)","source_id_and_acronym":"NCT03432156","lead_sponsor":"Beijing Friendship Hospital","biomarkers":" CEACAM5 • MUC16 • KRT19","pipe":"","alterations":" ","tags":["CEACAM5 • MUC16 • KRT19"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e autologous Tcm cellular immunotherapy"],"overall_status":"Unknown status","enrollment":" Enrollment 68","initiation":"Initiation: 04/03/2018","start_date":" 04/03/2018","primary_txt":" Primary completion: 12/01/2019","primary_completion_date":" 12/01/2019","study_txt":" Completion: 12/01/2020","study_completion_date":" 12/01/2020","last_update_posted":"2018-12-19"},{"id":"51cd6269-cf27-4c36-8112-14fea332df38","acronym":"OSNA-ORL","url":"https://clinicaltrials.gov/study/NCT02852343","created_at":"2021-01-18T14:00:00.505Z","updated_at":"2024-07-02T16:37:07.042Z","phase":"","brief_title":"One-step Nucleic Acid Amplification for Detecting Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma","source_id_and_acronym":"NCT02852343 - OSNA-ORL","lead_sponsor":"Rennes University Hospital","biomarkers":" KRT19","pipe":"","alterations":" ","tags":["KRT19"],"overall_status":"Completed","enrollment":" Enrollment 26","initiation":"Initiation: 01/05/2015","start_date":" 01/05/2015","primary_txt":" Primary completion: 12/21/2016","primary_completion_date":" 12/21/2016","study_txt":" Completion: 12/21/2016","study_completion_date":" 12/21/2016","last_update_posted":"2018-09-11"},{"id":"39533b63-4533-4b16-8890-0a2f2268c504","acronym":"","url":"https://clinicaltrials.gov/study/NCT03132740","created_at":"2021-01-18T15:26:06.858Z","updated_at":"2024-07-02T16:37:11.381Z","phase":"","brief_title":"Impact of Three-dimensional Visualization on Operation Strategy and Complications for Complex Hepatic Carcinoma","source_id_and_acronym":"NCT03132740","lead_sponsor":"Zhujiang Hospital","biomarkers":" CEACAM5 • AFP • KRT19 • CRP","pipe":"","alterations":" ","tags":["CEACAM5 • AFP • KRT19 • CRP"],"overall_status":"Unknown status","enrollment":" Enrollment 2000","initiation":"Initiation: 03/15/2017","start_date":" 03/15/2017","primary_txt":" Primary completion: 06/01/2019","primary_completion_date":" 06/01/2019","study_txt":" Completion: 06/01/2019","study_completion_date":" 06/01/2019","last_update_posted":"2018-04-19"},{"id":"9e7a1d02-0f6b-4b26-8512-96a02488fdfb","acronym":"","url":"https://clinicaltrials.gov/study/NCT03132649","created_at":"2021-01-18T15:26:05.039Z","updated_at":"2024-07-02T16:37:11.404Z","phase":"","brief_title":"Impact of Three-dimensional Visualization on Operation Strategy and Complications for Hilar Cholangiocarcinoma","source_id_and_acronym":"NCT03132649","lead_sponsor":"Zhujiang Hospital","biomarkers":" CEACAM5 • AFP • CD34 • KRT19 • CRP","pipe":"","alterations":" ","tags":["CEACAM5 • AFP • CD34 • KRT19 • CRP"],"overall_status":"Unknown status","enrollment":" Enrollment 300","initiation":"Initiation: 03/15/2017","start_date":" 03/15/2017","primary_txt":" Primary completion: 06/01/2019","primary_completion_date":" 06/01/2019","study_txt":" Completion: 06/01/2019","study_completion_date":" 06/01/2019","last_update_posted":"2018-04-19"}]